These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. Furman MI; Krueger LA; Linden MD; Barnard MR; Frelinger AL; Michelson AD J Am Coll Cardiol; 2004 Jun; 43(12):2319-25. PubMed ID: 15193700 [TBL] [Abstract][Full Text] [Related]
13. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. Schafer AI Tex Heart Inst J; 1997; 24(2):90-6. PubMed ID: 9205981 [TBL] [Abstract][Full Text] [Related]
15. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes. Keating FK; Whitaker DA; Sobel BE; Schneider DJ Thromb Res; 2004; 113(1):27-34. PubMed ID: 15081562 [TBL] [Abstract][Full Text] [Related]
16. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists. Ilveskero S; Lassila R Thromb Res; 2006; 117(3):291-7. PubMed ID: 15878612 [TBL] [Abstract][Full Text] [Related]
17. The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used. Aalto-Setälä K; Karhunen PJ; Mikkelsson J; Niemelä K J Thromb Thrombolysis; 2005 Aug; 20(1):57-63. PubMed ID: 16133898 [TBL] [Abstract][Full Text] [Related]
18. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G; Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196 [TBL] [Abstract][Full Text] [Related]
19. Use of GPIIb/IIIa inhibitors in cardiovascular medicine. Ahrens I; Peter K; Bode C Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283 [TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro. Hamilton SF; Miller MW; Thompson CA; Dale GL J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]